Literature DB >> 29911259

Intercellular communications-redox interactions in radiation toxicity; potential targets for radiation mitigation.

Bagher Farhood1, Nasser Hashemi Goradel2, Keywan Mortezaee3, Neda Khanlarkhani4, Ensieh Salehi4, Maryam Shabani Nashtaei4,5, Dheyauldeen Shabeeb6,7, Ahmed Eleojo Musa6,8, Hengameh Fallah9, Masoud Najafi10.   

Abstract

Nowadays, using ionizing radiation (IR) is necessary for clinical, agricultural, nuclear energy or industrial applications. Accidental exposure to IR after a radiation terror or disaster poses a threat to human. In contrast to the old dogma of radiation toxicity, several experiments during the last two recent decades have revealed that intercellular signaling and communications play a key role in this procedure. Elevated level of cytokines and other intercellular signals increase oxidative damage and inflammatory responses via reduction/oxidation interactions (redox system). Intercellular signals induce production of free radicals and inflammatory mediators by some intermediate enzymes such as cyclooxygenase-2 (COX-2), nitric oxide synthase (NOS), NADPH oxidase, and also via triggering mitochondrial ROS. Furthermore, these signals facilitate cell to cell contact and increasing cell toxicity via cohort effect. Nitric oxide is a free radical with ability to act as an intercellular signal that induce DNA damage and changes in some signaling pathways in irradiated as well as non-irradiated adjacent cells. Targeting of these mediators by some anti-inflammatory agents or via antioxidants such as mitochondrial ROS scavengers opens a window to mitigate radiation toxicity after an accidental exposure. Experiments which have been done so far suggests that some cytokines such as IL-1β, TNF-α, TGF-β, IL-4 and IL-13 are some interesting targets that depend on irradiated organs and may help mitigate radiation toxicity. Moreover, animal experiments in recent years indicated that targeting of toll like receptors (TLRs) may be more useful for radioprotection and mitigation. In this review, we aimed to describe the role of intercellular interactions in oxidative injury, inflammation, cell death and killing effects of IR. Moreover, we described evidence on potential mitigation of radiation injury via targeting of these mediators.

Entities:  

Keywords:  Bystander effect; Carcinogenesis; Cohort effect; Cytokines; Intracellular communication; Mitigation; Non-targeted effect; Radiation; Radiation disaster; Radiation toxicity; Radiotherapy; Redox system

Year:  2018        PMID: 29911259      PMCID: PMC6381372          DOI: 10.1007/s12079-018-0473-3

Source DB:  PubMed          Journal:  J Cell Commun Signal        ISSN: 1873-9601            Impact factor:   5.782


  19 in total

Review 1.  Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization.

Authors:  B Farhood; N H Goradel; K Mortezaee; N Khanlarkhani; E Salehi; M S Nashtaei; H Mirtavoos-Mahyari; E Motevaseli; D Shabeeb; A E Musa; M Najafi
Journal:  Clin Transl Oncol       Date:  2018-08-22       Impact factor: 3.405

2.  The radioprotective effect of N-acetylcysteine against x-radiation-induced renal injury in rats.

Authors:  Tolga Mercantepe; Atilla Topcu; Sema Rakici; Levent Tumkaya; Adnan Yilmaz; Filiz Mercantepe
Journal:  Environ Sci Pollut Res Int       Date:  2019-08-07       Impact factor: 4.223

Review 3.  Radiation-induced lung injury: latest molecular developments, therapeutic approaches, and clinical guidance.

Authors:  Lina Lu; Chao Sun; Qiong Su; Yanbin Wang; Jia Li; Zhong Guo; Lihua Chen; Hong Zhang
Journal:  Clin Exp Med       Date:  2019-07-16       Impact factor: 3.984

Review 4.  Cardiac inflammation and fibrosis following chemo/radiation therapy: mechanisms and therapeutic agents.

Authors:  Run Yang; Changming Tan; Masoud Najafi
Journal:  Inflammopharmacology       Date:  2021-11-23       Impact factor: 4.473

Review 5.  Nuclear and Radiological Emergencies: Biological Effects, Countermeasures and Biodosimetry.

Authors:  Elena Obrador; Rosario Salvador-Palmer; Juan I Villaescusa; Eduardo Gallego; Blanca Pellicer; José M Estrela; Alegría Montoro
Journal:  Antioxidants (Basel)       Date:  2022-05-31

Review 6.  Cardiac Remodelling Following Cancer Therapy: A Review.

Authors:  Tan Panpan; Du Yuchen; Shi Xianyong; Liu Meng; He Ruijuan; Dong Ranran; Zhang Pengyan; Li Mingxi; Xie Rongrong
Journal:  Cardiovasc Toxicol       Date:  2022-07-25       Impact factor: 2.755

7.  Cardiac fibrosis in oncologic therapies.

Authors:  René R Sevag Packard
Journal:  Curr Opin Physiol       Date:  2022-08-08

Review 8.  Targeting of cancer cell death mechanisms by resveratrol: a review.

Authors:  Xiao Fu; Mu Li; Cuilian Tang; Zezhi Huang; Masoud Najafi
Journal:  Apoptosis       Date:  2021-09-25       Impact factor: 4.677

Review 9.  Radiation-induced myocardial fibrosis: Mechanisms underlying its pathogenesis and therapeutic strategies.

Authors:  Bin Wang; Huanhuan Wang; Mengmeng Zhang; Rui Ji; Jinlong Wei; Ying Xin; Xin Jiang
Journal:  J Cell Mol Med       Date:  2020-06-14       Impact factor: 5.310

10.  Blocking C-Raf alleviated high-dose small-volume radiation-induced epithelial mesenchymal transition in mice lung.

Authors:  Zhen-Yu Hong; Sanke Li; Xiaomei Liu; Xiao-Min Leng; Zhanhui Miao; Xiaohong Kang; Hongrui Niu; Ming-Qing Gao; Ping Lu
Journal:  Sci Rep       Date:  2020-07-07       Impact factor: 4.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.